New Drugs for Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Disease Coming Down the Pipeline, 2018: Researchmoz

Researchmoz added Most up-to-date research on "Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018" to its huge collection of research reports.

This report provides an overview of the non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players active in this space, and also features data for dormant and discontinued projects.

Get Free PDF Brochure For More Technical Insights@ https://www.researchmoz.us/enquiry.php?type=S&repid=1701729

NAFLD and NASH represent considerable burdens for healthcare systems, particularly in developed countries where NAFLD is the most common liver disorder.

NAFLD is strongly related to insulin resistance and is therefore often treated by therapeutics originally intended for use in diabetes mellitus. Up to 80% of obese people have NAFLD, which is usually asymptomatic or mildly symptomatic.

NASH is a severe form of NAFLD. It presents as a swelled or inflamed liver and may result in cirrhosis and consequent liver failure. As populations age the incidence of NASH is likely to rise and become a major healthcare concern for western systems.

Scope

- Which companies are the most active within the pipeline for NAFLD and NASH therapeutics?
- Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened within this field?

View Complete TOC with tables & Figures @ https://www.researchmoz.us/non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepatitis-nash-drug-development-pipeline-review-2018-report.html/toc

Reasons to buy

- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Contents

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Gastrointestinal Report Coverage 9
2.2 Non-Alcoholic Steatohepatitis (NASH) - Overview 9
2.3 Non Alcoholic Fatty Liver Disease (NAFLD) - Overview 9
3 Therapeutics Development 10
3.1 Non-Alcoholic Steatohepatitis (NASH) 10
3.2 Non Alcoholic Fatty Liver Disease (NAFLD) 29
4 Therapeutics Assessment 37
4.1 Non-Alcoholic Steatohepatitis (NASH) 37
4.2 Non Alcoholic Fatty Liver Disease (NAFLD) 48
5 Companies Involved in Therapeutics Development 58
5.1 Non-Alcoholic Steatohepatitis (NASH) 58
5.2 Non Alcoholic Fatty Liver Disease (NAFLD) 103
6 Dormant Projects 124
6.1 Non-Alcoholic Steatohepatitis (NASH) 124
6.2 Non Alcoholic Fatty Liver Disease (NAFLD) 127
7 Discontinued Products 129
7.1 Non-Alcoholic Steatohepatitis (NASH) 129
7.2 Non Alcoholic Fatty Liver Disease (NAFLD) 130
8 Product Development Milestones 131
8.1 Non-Alcoholic Steatohepatitis (NASH) 131
8.2 Non Alcoholic Fatty Liver Disease (NAFLD) 143
9 Appendix 158
9.1 Methodology 158
9.2 Coverage 158
9.3 Secondary Research 158
9.4 Primary Research 158
9.5 Expert Panel Validation 158
9.6 Contact Us 159
9.7 Disclaimer 159
...

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1701729

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com

This release was published on openPR.